| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Operating revenues: | ||||||
License revenues | ||||||
- | 500 | - | ||||
Operating expenses: | ||||||
Research and development | ||||||
7,900 | 4,522 | 3,206 | ||||
General and administrative | ||||||
3,693 | 2,739 | 1,313 | ||||
Total operating expenses | ||||||
11,593 | 7,261 | 4,519 | ||||
Operating loss | ||||||
-11,593 | -6,761 | -4,519 | ||||
Other (income) expense: | ||||||
Governmental assistance - research incentives | ||||||
856 | 1,214 | 244 | ||||
Other (income) expense, net | ||||||
119 | -68 | 6 | ||||
Change in fair value of warrant liability | ||||||
- | 39 | -9 | ||||
Total other (income) expense | ||||||
975 | 1,107 | 259 | ||||
Loss before income tax expense | ||||||
-10,618 | -5,654 | -4,260 | ||||
Income tax expense | ||||||
31 | 80 | - | ||||
Net loss | ||||||
-10,649 | -5,734 | -4,260 | ||||
Other comprehensive income | ||||||
Unrealized gain on marketable securities | ||||||
2 | - | - | ||||
Net loss and comprehensive loss | ||||||
-10,647 | -5,734 | - | ||||
Basic and diluted net loss per share (in dollars per share) | ||||||
-0.89 | -0.74 | -0.72 | ||||
Weighted average shares outstanding – basic and diluted (in shares) | ||||||
11,987 | 7,743 | 5,935 | ||||